Evidence map›Paper›PMID 27101025›Full record

ArticleThe Journal of pathology2016

Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma.

Lien Spans, Christopher Dm Fletcher, Cristina R Antonescu, Alexandre Rouquette, Jean-Michel Coindre, Raf Sciot, Maria Debiec-Rychter

Abstract read
In one paragraph

Article in The Journal of pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. GLI1-altered mesenchymal tumors of the head and neck.Seminars in diagnostic pathology · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Cells · 2025
    Review
  14. Frontiers in oncology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2024
    Article
  19. Review
  20. Gastroblastoma with a novel ACTB::GLI1 gene fusion in a 19-year-old male.Virchows Archiv : an international journal of pathology · 2024
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lien SpansDepartment of Human Genetics, KU Leuven and University Hospitals Leuven, Belgium.
Christopher Dm FletcherDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
Cristina R AntonescuDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Alexandre RouquetteDepartment of Pathology, Cochin Hospital, Assistance Publique-, Hôpitaux de Paris, France.
Jean-Michel CoindreDepartment of Pathology, Institut Bergonié, Bordeaux, France.
Raf SciotDepartment of Pathology, KU Leuven and University Hospitals Leuven, Belgium.
Maria Debiec-RychterDepartment of Human Genetics, KU Leuven and University Hospitals Leuven, Belgium.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
SPORE in Soft Tissue SarcomaP50CA140146 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SPRIGGS, DAVID R · 2010 to 2014
$11.1M
NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA140146
6 · The paper itself

Abstract

Plexiform fibromyxomas are rare neoplasms, being officially recognized as a distinct entity among benign mesenchymal gastric tumours in the 2010 WHO Classification of Tumours of the Digestive System. Characteristically, these tumours have a multinodular/plexiform growth pattern, and histologically contain variably cellular areas of bland myofibroblastic-type spindle cells embedded in an abundant myxoid matrix, rich in capillary-type vessels. As yet, the molecular and/or genetic features of these tumours are unknown. Here we describe a recurrent translocation, t(11;12)(q11;q13), involving the long non-coding gene metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and the gene glioma-associated oncogene homologue 1 (GLI1) in a subgroup of these tumours. The presence of the fusion transcript in our index case was confirmed using polymerase chain reaction (PCR) on genomic DNA, followed by Sanger sequencing. We showed that the truncated GLI1 protein is overexpressed and retains its capacity to transcriptionally activate its target genes. A specific FISH assay was developed to detect the novel MALAT1-GLI1 translocation in formalin-fixed, paraffin-embedded (FFPE) material. This resulted in the identification of two additional cases with this fusion and two cases with polysomy of the GLI1 gene. Finally, immunohistochemistry revealed that the GLI1 protein is exclusively overexpressed in those cases that harbour GLI1/12q13 genomic alterations. In conclusion, overexpression of GLI1 through a recurrent MALAT1-GLI1 translocation or GLI1 up-regulation delineates a pathogenically distinct subgroup of plexiform fibromyxomas with activation of the Sonic Hedgehog signalling pathway. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Indexed as

Translocation, GeneticAdolescentAdultAgedCarcinogenesisFemaleFibromaGene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingHumansIn Situ Hybridization, FluorescenceMaleMiddle AgedNeoplasm Recurrence, LocalOncogene FusionRNA, Long NoncodingGLI1 protein, humanMALAT1 long non-coding RNA, humanRNA, Long NoncodingZinc Finger Protein GLI1GLI1MALAT1oncogenic fusionplexiform fibromyxoma

Identifiers

PMID27101025
PMCPMC5586099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.